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ABSTRACT
Introduction: Although several registries collecting data
of patients with kidney diseases exist, only a few specifi-
cally collect data relating to renal biopsy. Kidney biopsy
has been performed routinely in Pisa since 1977; the aim
of this study was to report the relative frequency of
nephropathies according to gender, age at time of bio-
psy, clinical presentation and renal function, based on hi-
stological diagnoses during the years 1977 through 2005.
During this time, 3,810 kidney biopsies were performed,
of which 89.3% were from native (n=3,446) and 10.7%
from transplant kidneys. Throughout this period, 5% of
renal biopsies were not diagnostic, so in this paper we
report data regarding 3,269 native kidney nephropathies. 
Methods: During the years 1977 through 2005, data for
renal biopsies were collected on specific registers filled
out by clinicians. Information collected in the database
included a variety of indicators, such as clinical anamne-
sis, creatinine clearance, daily proteinuria, hemoglobin
levels, blood pressure, height and weight, clinical pre-
sentation, and current medications. Clinical presentation
was defined as urinary abnormalities (UA), nephrotic syn-
drome (NS) and acute nephritic syndrome (ANS). Renal
diseases were divided into 4 major categories: primary
glomerulonephritis (GN), secondary GN, tubulointerstitial
nephropathies (TIN) and vascular nephropathies (VN). 
Results: From 1977 up to 1987, a mean of 95 ± 18 renal
biopsies/year were performed; this number significantly
increased to 185 ± 22 renal biopsies/year (range 138-200) 
(p<0.001) in the following period (1988-2005). Renal bio-
psy was more frequently performed in males (59%) com-
pared with females (41%). Of all diseases of the native
kidney, primary GN was the most frequent (66%), fol-
lowed by secondary GN (25.6%), TIN (4.2%) and VN
(4.2%). The type of primary GN with the highest fre-
quency was mesangial GN (both IgA and non-IgA)
(45.7%), followed by membranous GN (23%), focal seg-
mental glomerulosclerosis (19.8%), minimal change di-
sease (5.3%), crescentic GN (4.2%) and postinfectious
GN (2%). In terms of age, renal biopsy was more fre-
quently performed in patients aged 20 to 60 years, and
nearly 60% of patients presented a glomerular filtration
rate (GFR) >60 ml/min at the time of biopsy. The main cli-
nical reason for performing renal biopsy was UA, in all
the types of nephropathies.
Conclusions: We confirm data that renal diseases are
more frequent in men, with the exception of secondary
GN. The mean age at diagnosis was 42 years resulting
from the tendency not to perform renal biopsies in chil-
dren and in elderly patients. Renal biopsy was mainly
performed in patients with GFR >60 ml/min and asymp-
tomatic urinary abnormalities suggesting concern on the
part of clinicians regarding glomerular diseases. The ten-
dency to perform renal biopsies has been significantly
increasing throughout our follow-up period.
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INTRODUCTION
Clinical epidemiological research is the key feature of the
development of good quality medicine treatment.
Although there are several registries collecting data from
patients with kidney disease, only a few specifically col-
lect data relating to renal biopsy. One such registry is the
Italian Registry of Renal Biopsies (IRRB) which since 1987
has collected all data (age, gender, clinical presentation,
renal function and histological diagnosis) regarding biop-
sies performed in Italy (1). There are several epidemiologi-
cal population-based studies of biopsy-proven
nephropathies with detailed clinical-pathological correla-
tions that may different according to the country or region
analyzed (2-8). The Hospital of Pisa was one of first to
introduce renal biopsy in Italy: kidney biopsy has routinely
been performed in Pisa since 1977. Since 1977 and up to
December 2005, the 2 renal units in Pisa performed 3,446
biopsies from native and 364 biopsies from transplant kid-
neys. Throughout this period, 5% of renal biopsies were
not diagnostic, so in this paper we report data regarding
3,269 native kidney nephropathies. 
The aim of this paper is to report the relative frequency of
native kidney nephropathies in our registry according to
gender, age at time of biopsy, clinical presentation and
renal function, based on the histological diagnosis, and to
identify the most frequent clinical syndromes and the
manifestations of each renal disease.
STUDY POPULATION AND METHODS
In Pisa, 3,810 renal biopsies were performed during the
years 1977 through 2005, by its 2 renal units (the
University Nephrology Unit and the Nephrology and
Dialysis Gabriele Monasterio Unit) of which 89.3% were
from native and 10.7% from transplant kidneys. We here
evaluated data regarding the 3,269 diagnostic native kid-
ney biopsies.
These data were collected on specific registers filled out by
clinicians. Information collected in the database included a
variety of indicators, such as clinical anamnesis, creatinine
clearance, daily proteinuria, hemoglobin levels, blood pres-
sure, height and weight (when available), clinical presenta-
tion and current medications. This clinical information is
more complete in the registers collected from 1987
through 2005, compared with the data relative to the previ-
ous 10 years (from 1977 to 1987) which report only the his-
tological diagnosis, personal data and limited clinical infor-
mation. Nephrotic syndrome (NS) was defined as protein-
uria greater than 3.5 g/day per 1.73 m2 and serum albumin
less than 2.5 g/dL. Acute nephritic syndrome (ANS) was
defined as hematuria, hypertension, oliguria, edema and
reduced glomerular filtration rate (GFR). Urinary abnormali-
ties (UA) included persistent nonnephrotic proteinuria
and/or microscopic hematuria. Hypertension was consid-
ered when blood pressure was higher than 140/90 mm Hg.
Acute renal failure (ARF) was defined as a rapid deteriora-
tion of GFR. GFR was calculated according to the
Modification of Diet in Renal Disease (MDRD) formula.
Renal diseases, in accordance with the Italian Register of
Renal Biopsies (IRRB), were divided into 4 major cate-
gories: primary glomerulonephritis (GN), secondary GN,
tubulointerstitial nephropathies (TIN) and vascular
nephropathies (VN).
We have considered primary GN (group 1) to include mini-
mal change disease, mesangial GN (IgA, non-IgA mesan-
gial nephropathy and Schönlein-Henoch syndrome),
membranous GN, focal segmental glomerulosclerosis
(FSGS), membranoproliferative GN (MPGN), crescentic
GN and postinfection GN.
Secondary GN (group 2) includes a large group of dis-
eases: immune-mediated GN (systemic lupus erythemato-
sus, necrotizing vasculitis), metabolic and hereditary disor-
der–associated GN (amyloidosis, diabetes mellitus,
Alport’s syndrome, Fabry’s disease and other hereditary
disorders), dysgammaglobulinemia-associated GN (essen-
tial mixed cryoglobulinemia, Waldenström’s macroglobu-
linemia, monoclonal gammopathy, multiple myeloma-
associated renal disease and light chain disease).
Tubulointerstitial nephropathies (TIN) (group 3) include
chronic TIN, acute TIN, acute tubular necrosis and chronic
pyelonephritis.
Benign nephroangiosclerosis, thrombotic microangiopa-
thy, malignant nephroangiosclerosis, cortical necrosis,
preeclampsia acute ischemic damage, pre-acute renal
insufficiency and renal vessel thrombosis were classified
as vascular nephropathies (VN) (group 4). Into this group
we have also placed the few cases (2) of loin pain-hema-
turia syndrome. 
Data regarding 5% of all biopsies, which could not be
adequately classified due to inadequate sampling, normal
renal tissue or end-stage renal disease, were not included
in our analysis.
Statistical analysis
Each year, data were stored in a database file (Microsoft
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Access 2000). All statistical analysis was performed using
the statistical package SPSS for Windows version 10.0.6
(SPSS Inc, Chicago, IL, USA). Data were tested for normal
distribution with the Kolmogorov-Smirnov test. The values
are expressed as medians when the parameters did not fit
into a normal (Gaussian) distribution. The chi-square test
and Fisher’s test were used to compare qualitative vari-
ables. A p value of less than 0.05 (by 2-tailed test) was
considered to indicate statistical significance.
RESULTS
From 1977 up to 1987, a mean of 95 ± 18 renal
biopsies/year were performed; this number significantly
increased, roughly tripling, to 185 ± 22 renal biopsies/year
(range 138-200) (p<0.001) in the following period (1988-
2005) (Fig. 1). Together the 2 Pisa nephrology units per-
formed 3,446 biopsies from native kidneys (90.6%) and
364 biopsies from transplant kidneys (9.4%) in a period of
28 years. We report here data regarding 3,269 diagnostic
renal biopsies. 
Of all diseases of native kidney, primary GN was the most
frequent (71.6%), followed by secondary GN (18.4%), TIN
(5.7%) and VN (4.3%).
The type of primary GN with the highest frequency was
mesangial GN (39.6%), followed by membranous GN
(20.1%), FSGS (18.6%), MPGN (11%), crescentic GN
(4.3%), minimal change disease (3.5%) and postinfectious
GN (3%) (Fig. 2).
Primary GN was more frequent in males (64.4%) com-
pared with females (35.6%); this was also true for TIN
(males 64%, females 36%) and for VN (males 65%,
females 35%). In contrast, secondary GN was more fre-
quent in females (61.2% female vs. 38.8% males). The
diseases with a higher frequency in males were mesangial
GN (67.5% males, 32.5% females). By contrast, as is well-
known, the more common disease in females are the
immunomediated GNs, in particular systemic lupus ery-
thematosus (89.7% females vs. 10.3% males). 
In terms of age, biopsies were more frequently performed
in patients aged 20-60 years. Primary GNs were found in
patients 41.52 ± 1.92 years old, secondary GN in patients
47.2 ± 3.7 years old, TIN in those 46.23 ± 1.73 years old
and VN in those 49.28 ± 2.59 years old (p<0.05 for group
1, vs. groups 2-4).
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Fig. 1 - Number of kidney biopsies each year, 1977-2005. Fig. 2 - Frequency of histological diagnosis of primary glo-
merulonephritides. FSGS = focal segmental glomerulosclero-
sis; GN = glomerulonephritis; MPGN = membranoproliferative
GN.
Fig. 3 - Renal function at time of biopsy: percentages of
patients undergoing a renal biopsy who had different stages
of chronic kidney disease (CKD). GFR was calculated accor-
ding to the MDRD formula, and stages of CKD were classi-
fied according to K/DOQI guidelines.
The great majority (59.7%) of patients underwent a renal
biopsy with a GFR >60 ml/min (stage I-II chronic kidney
disease [CKD]; Kidney Disease Outcomes Quality Initiative
[K/DOQI] guidelines) with 15.6% in stage IV-V, K/DOQI
(Fig. 3). When patients were divided into groups according
to renal pathology, a large percentage of patients affected
by TIN (group 3) and secondary GN (group 2) showed a
reduced GFR at the time of biopsy (Fig. 4). 
Urinary abnormalities were the main indications to perform
a renal biopsy in all the different biopsied nephropathies:
63% of cases of primary GN, 58% of cases of secondary
GN, 79% cases of TIN and 72% of cases of VN. The class
of nephropathy that most frequently presented with NS
was secondary GN (39%) followed by primary GN (30%)
(Fig. 5). 
The percentage of patients from outside the region of
Tuscany who received renal biopsies in the different peri-
ods of observation was also investigated. The means of 3
different periods were compared: namely 1980-1982 vs.
1990-1992, and vs. 2000-2002. The percentage of
patients from outside Tuscany who were biopsied in Pisa
decreased from 41.6% ± 4% (1980-1982) to 37% ± 5%
(1990-1992) and 33.4% ± 3.7 % in the final period (2000-
2002).
The percentages of cases of IgA nephropathy (IgAN) and
of FSGS diagnosis with respect to the total number of
cases of primary GN throughout the years recorded are
shown in Figures 6 and 7.
DISCUSSION
This article reports on a 28-year retrospective epidemio-
logical study of native kidney biopsies performed in the
Hospital of Pisa since 1977. The practice of renal biopsy
has been increasing during the last few decades; from
1977 to 1987, a mean of 95 ± 18 renal biopsies/year  were
performed. This number significantly increased to 185 ±
22 renal biopsies/year (range 138-200) (p<0.001) in the
following period (1988 to 2005). In Italy as a whole, about
99 renal biopsies/million persons per year are actually per-
formed (9-11). In Tuscany, this procedure was first intro-
duced by Prof. Quirino Maggiore in the late 1970s and is
still performed more frequently than in other Italian regions
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Fig. 4 - Renal function
at time of biopsy in 4
groups of renal biopsy
patients classified by
nephropathy: group 1 =
primary glomerulo-
nephritis (GN); group 2
= secondary GN; group
3 = tubulointerstitial
nephropathies (TIN);
and group 4 = vascular
nephropathies (VN).
GFR was calculated
according to the MDRD
formula, and stages of
CKD were classified
according to K/DOQI
guidelines.
(about 166 biopsies/million persons per year). In particular,
from 1987 to 2005 about 185 renal biopsies/year were
evaluated in Pisa – a geographical area with a population
of roughly 0.2 million persons, a frequency of renal biop-
sies per person that is greatly above the Italian and
regional average. This is due to the fact that data from all
kidney biopsies performed in northwest Tuscany are col-
lected for diagnosis by the nephrology units of Pisa; fur-
thermore, Pisa is still receiving a large number of patients
suffering from renal disease, from other regions of Italy.
The percentage of patients from outside the region of
Tuscany who received a renal biopsy decreased through-
out the study period, but it is still very high – over 30% of
the total number.
According to data from other registers, we can confirm
that kidney biopsies have been more frequently performed
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Fig. 5 - Clinical presen-
tation at the time of
biopsy according to the
type of nephropathy.
Nephrotic syndrome
(NS), urinary abnormali-
ties (UA) and acute
nephritic syndrome
(ANS).
Fig. 6 - The percentage of cases of IgA nephropathy (IgAN)
diagnosed in the total number of cases of primary glomeru-
lonephritis recorded for 1977-2005.
Fig. 7 - The percentage of cases of focal segmental glomeru-
losclerosis (FSGS) diagnosed in the total number of primary
glomerulonephritis cases recorded for 1977-2005.
for the diagnosis of primary GN compared with secondary
GN, TIN and VN (Fig. 2.). A male predominance of the
main clinical syndromes has been observed in the whole
population, as occurs in the majority of renal pathologies
undergoing kidney biopsy (1). Furthermore, primary GN,
TIN and VN are more frequent in men – in particular,
mesangial GN and both IgA and non-IgA GN. The higher
relative frequency of secondary GN in women may be due
to the higher frequency of immune-mediated disease in
this gender. In particular, in this group of patients, renal
biopsy was mainly performed in systemic lupus erythe-
matosus.
In our study, we found that all categories of renal disease
occur mainly in patients aged 20-60 years. This can be
explained by the choice to perform an invasive procedure
like biopsy principally in patients with a long life expectan-
cy and in the case of in children, only in those with persis-
tent disease who present with major symptoms. As
expected, the oldest patients are in group 4 (VN) with a
mean age at the time of diagnosis of 49.2 ± 2.5, versus
41.52 ± 1.92 years (p<0.05) in patients affected by primary
GN.
Urinary abnormalities were the main indications to perform
a renal biopsy in our registry, in accordance with the
national Italian registry of renal biopsy (1), and in contrast
to other registers where nephrotic syndrome is the main
indication for kidney biopsy (12). Furthermore, we note
that in our database, urinary abnormalities are a more fre-
quent reason for performing a renal biopsy even com-
pared with the data of Gesualdo and colleagues from the
Italian registry (1).
Moreover, the great majority (59.7%) of patients were sub-
mitted to renal biopsy with a GFR >60 ml/min (stage I-II
CKD; K/DOQI) with 15.6% in stage IV-V, K/DOQI (Fig. 4).
When patients were divided into groups according to renal
pathology, a large percentage of patients affected by TIN
(group 3) and secondary GN (group 2) showed a reduced
GFR at the time of biopsy (Fig. 5). 
As in other European countries, we have not observed any
increase in the annual incidence of FSGS as a cause of
nephrotic syndrome, as has been shown in other reports,
mainly from the United States and Singapore (13, 14). In
fact, 3 studies in the United States have disclosed that
since 1995, FSGS is the most common cause of adult
nephrotic syndrome (14, 15). Moreover, racial differences,
nutritional behaviors and environmental factors may have
been implicated in this difference in our population.
As was expected, IgAN is the most common primary GN
during the whole study period in the general population of
the area. The new information furnished by this epidemio-
logical study is that the risk of occurrence of IgAN has
become similar in the population living in our region, what-
ever the age group, during the last period studied. The
mean age of patients undergoing renal biopsy progres-
sively increased during the study period, and the policy of
referring for renal biopsy was expanded more and more in
the elderly as the consequence of the increase in average
lifetime. Thus, the incidence of IgAN not only remained
similar throughout the period under study, but also
became similar in each age group during the last period
studied. The stability of the annual incidence of IgAN
diagnosis and of end-stage renal disease due to IgAN
during this 27-year prospective study strongly suggests
that immunogenetic factors could be more important than
environmental factors in the onset of IgAN (7, 8).
In conclusion, our study gives further epidemiological
information on the evolution of native kidney nephropathy
incidence in every age group of a general population dur-
ing a long observation period of 27 years. We believe that
the collection of data on renal biopsies is a useful tool for
nephrologists and the availability of this data will help epi-
demiological studies in health care to answer the several
open questions regarding both prevention and treatment
of renal disease. 
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